Salud financiera de hoja de balance de ThermoGenesis Holdings

Salud financiera controles de criterios 0/6

ThermoGenesis Holdings tiene un patrimonio de los accionistas total de $-1.1M y una deuda total de $4.2M, lo que sitúa su ratio deuda-patrimonio en -386.9%. Sus activos y pasivos totales son $10.1M y $11.2M respectivamente.

Información clave

-386.9%

Ratio deuda-patrimonio

US$4.21m

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	US$1.18m
Patrimonio	-US$1.09m
Total pasivo	US$11.17m
Activos totales	US$10.09m

Actualizaciones recientes sobre salud financiera

Recent updates

It's Down 52% But ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Could Be Riskier Than It Looks

Apr 17

Does ThermoGenesis Holdings' (NASDAQ:THMO) CEO Salary Compare Well With Industry Peers?

Dec 15

ThermoGenesis EPS misses by $0.27, misses on revenue

Nov 12

Análisis de la situación financiera

Pasivos a corto plazo: THMO tiene patrimonio neto negativo. Es una situación más grave que activos a corto plazo que no cubren pasivos a corto plazo.

Pasivo a largo plazo: THMO tiene patrimonio neto negativo. Esta situación es más grave que el hecho de que los activos a corto plazo no cubran los pasivos a largo plazo.

Historial y análisis de deuda-patrimonio

Nivel de deuda: THMO tiene patrimonio negativo, una situación más grave que un alto nivel de endeudamiento.

Reducción de la deuda: THMO tiene patrimonio neto negativo, por lo que no necesitamos comprobar si su deuda se ha reducido con el tiempo.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: THMO tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: THMO tiene menos de un año de cash runway si el flujo de caja libre sigue creciendo a tasas históricas de 6.4% cada año.

Salud financiera de hoja de balance de ThermoGenesis Holdings

Salud financiera controles de criterios 0/6

Información clave

Actualizaciones recientes sobre salud financiera

ThermoGenesis Holdings, Inc. announced delayed 10-Q filing

ThermoGenesis Holdings, Inc. Receives A Notice of Default from Boyalife Group (USA), Inc

ThermoGenesis Holdings Receives Notice from Nasdaq Due to Non-Compliance with Minimum of $2.5 Million in Stockholders’ Equity for Continued Listing Under Nasdaq’s Listing Rule 5550(b)(1)

ThermoGenesis Holdings, Inc. announced delayed 10-Q filing

ThermoGenesis Holdings Receives Notice from Nasdaq Regarding Non-Compliance with Nasdaq’s Listing Rule 5550(b)(1)

ThermoGenesis Holdings, Inc. announced delayed annual 10-K filing

Recent updates

ThermoGenesis Holdings, Inc. announced delayed 10-Q filing

ThermoGenesis Holdings, Inc. Receives A Notice of Default from Boyalife Group (USA), Inc

ThermoGenesis Holdings Receives Notice from Nasdaq Due to Non-Compliance with Minimum of $2.5 Million in Stockholders’ Equity for Continued Listing Under Nasdaq’s Listing Rule 5550(b)(1)

ThermoGenesis Holdings, Inc. announced delayed 10-Q filing

ThermoGenesis Holdings Receives Notice from Nasdaq Regarding Non-Compliance with Nasdaq’s Listing Rule 5550(b)(1)

ThermoGenesis Holdings, Inc. announced delayed annual 10-K filing

New major risk - Share price stability

ThermoGenesis Holdings Receives Letter from The Nasdaq Stock Market Regarding Non-Compliance with the Minimum Bid Price Requirement for Continued Listing on the Nasdaq Capital Market

ThermoGenesis Holdings, Inc. has filed a Follow-on Equity Offering in the amount of $1.288 million.

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

New minor risk - Share price stability

ThermoGenesis Holdings, Inc. to Report Q3, 2023 Results on Nov 13, 2023

ThermoGenesis Holdings, Inc., Annual General Meeting, Dec 14, 2023

Consensus revenue estimates fall by 25%

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

ThermoGenesis Holdings, Inc. to Report Q2, 2023 Results on Aug 10, 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

ThermoGenesis Holdings, Inc. to Report Q1, 2023 Results on May 15, 2023

It's Down 52% But ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Could Be Riskier Than It Looks

Forecast breakeven date moved forward to 2023

Full year 2022 earnings: EPS and revenues miss analyst expectations

ThermoGenesis Regains Compliance with Nasdaq Minimum Bid Price Requirement

Price target decreased to US$1.00

Less than half of directors are independent

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

ThermoGenesis Holdings, Inc. to Report Q1, 2023 Results on Nov 10, 2022

ThermoGenesis Holdings, Inc., Annual General Meeting, Dec 15, 2022

ThermoGenesis Holdings, Inc. has completed a Composite Units Offering in the amount of $2.0547 million.

Nasdaq Grants Extension to ThermoGenesis Holdings to Regain Compliance

Forecast breakeven date pushed back to 2024

Less than half of directors are independent

ThermoGenesis reports Q2 results

ThermoGenesis Holdings, Inc. to Report Q4, 2022 Results on Aug 11, 2022

ThermoGenesis Holdings, Inc. Announces Board Changes

ThermoGenesis Holdings, Inc. Board Changes

ThermoGenesis Holdings, Inc. to Report Q1, 2022 Results on May 19, 2022

ThermoGenesis Holdings, Inc. announced delayed 10-Q filing

Forecast to breakeven in 2022

Price target decreased to US$6.00

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Third quarter 2021 earnings released: US$0.15 loss per share (vs US$0.37 loss in 3Q 2020)

Is ThermoGenesis Holdings (NASDAQ:THMO) Using Too Much Debt?

Thermogenesis Awards Nih Sbir Phase I Grant to Develop Key Cell Processing Disposable for Quintessence Automated Manufacturing of Gene-Engineered Autologous Cell (Geac) Therapies

Consensus forecasts updated

Second quarter 2021 earnings released: US$0.38 loss per share (vs US$1.02 loss in 2Q 2020)

Is ThermoGenesis Holdings (NASDAQ:THMO) A Risky Investment?

Consensus revenue estimates fall to US$9.94m

First quarter 2021 earnings released: US$0.21 loss per share (vs US$1.11 loss in 1Q 2020)

When Will ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Become Profitable?

Consensus revenue estimates fall to US$13.6m

Full year 2020 earnings released: US$2.60 loss per share (vs US$3.36 loss in FY 2019)

ThermoGenesis Holdings, Inc. to Report Q4, 2020 Results on Mar 17, 2021

Here's Why ThermoGenesis Holdings (NASDAQ:THMO) Can Afford Some Debt

New 90-day high: US$3.85

Thermogenesis Holdings, Inc. Launches A Gmp Compliant Automated Cell Washing and Reformulation System -- Pxp™-Lavare -- for Car-T Manufacturing

New 90-day high: US$2.73

New 90-day low: US$2.10

Does ThermoGenesis Holdings' (NASDAQ:THMO) CEO Salary Compare Well With Industry Peers?

Earnings beat expectations, revenue disappoints

Third quarter 2020 earnings released: US$0.37 loss per share

ThermoGenesis EPS misses by $0.27, misses on revenue

ThermoGenesis Holdings, Inc. to Report Q3, 2020 Results on Nov 12, 2020

New 90-day low: US$2.55

New 90-day low: US$3.24

New 90-day low - US$3.66

First half earnings released

ThermoGenesis Holdings, Inc. to Report Q2, 2020 Results on Aug 12, 2020

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio